{"title": "Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis", "author": "Roy; Alvaro; Tom\u00e9; Irene; Romero; Beatriz; Lorente-Leal; V\u00edctor; Infantes-Lorenzo; Jos\u00e9 A; Dom\u00ednguez; Mercedes; Mart\u00edn; Carlos; Aguil\u00f3; Nacho; Puentes; Eugenia; Rodr\u00edguez; Esteban; De Juan; Luc\u00eda; Risalde; Mar\u00eda A; Gort\u00e1zar; Christian; Lucas; Bezos; Javier", "url": null, "hostname": null, "description": "Effective vaccines against tuberculosis (TB) are needed in order to prevent TB transmission in human and animal populations. Evaluation of TB vaccines may be facilitated by using reliable animal models that mimic host pathophysiology and natural transmission of the disease as closely as possible. In this study, we evaluated the immunogenicity and efficacy of two attenuated vaccines, BCG and MTBVAC, after each was given to 17 goats (2 months old) and then exposed for 9 months to goats infected with M. caprae. In general, MTBVAC-vaccinated goats showed higher interferon-gamma release than BCG vaccinated goats in response to bovine protein purified derivative and ESAT-6/CFP-10 antigens and the response was significantly higher than that observed in the control group until challenge. All animals showed lesions consistent with TB at the end of the study. Goats that received either vaccine showed significantly lower scores for pulmonary lymph nodes and total lesions than unvaccinated controls. Both MTBVAC and BCG vaccines proved to be immunogenic and effective in reducing severity of TB pathology caused by M. caprae. Our model system of natural TB transmission may be useful for evaluating and optimizing vaccines.", "sitename": "BioMed Central Ltd.", "date": "2019-10-15", "cleaned_text": "Por favor, usa este identificador para citar o enlazar este \u00edtem: http://hdl.handle.net/10668/3149 |T\u00edtulo :||Evaluation of Complutense de Madrid, Madrid, Spain. [Dom\u00ednguez,M] Servicio de Inmunolog\u00eda Microbiana, Centro Nacional de Microbiolog\u00eda, Instituto de Investigaci\u00f3n Carlos III, Majadahonda, Madrid, Spain. [Mart\u00edn,C; Aguil\u00f3,N] Grupo de Gen\u00e9tica de Micobacterias, Departamento de Microbiolog\u00eda y Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain. [Mart\u00edn,C; Aguil\u00f3,N] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. [Mart\u00edn,C] Servicio de Microbiolog\u00eda, Hospital Universitario Miguel Servet, IIS Arag\u00f3n, Zaragoza, Spain. [de Juan,L; Dom\u00ednguez,L; Bezos,J] Dpto. de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain. [Risalde,MA] Dpto. de Anatom\u00eda y Anatom\u00eda Patol\u00f3gica Comparadas, Universidad de C\u00f3rdoba, C\u00f3rdoba, Spain. [Risalde,MA] Infectious Diseases Unit, Instituto Maimonides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Hospital Universitario Reina Sof\u00eda de C\u00f3rdoba, Universidad de C\u00f3rdoba, C\u00f3rdoba, Spain. [Gort\u00e1zar,C] SaBio (Health and Biotechnology), Instituto de Investigaci\u00f3n en Recursos Cineg\u00e9ticos IREC C\u00f3rdoba (IMIBIC)](/handle/10668/22653) [SAS - Hospital Universitario Reina Sof\u00eda](/handle/10668/22732) Ficheros en este \u00edtem: |Fichero||Descripci\u00f3n||Tama\u00f1o||Formato| [Visualizar/Abrir](/bitstream/10668/3149/6/Roy_EvaluationOfTheImmunogenicity.pdf) Este \u00edtem est\u00e1 protegido por copyright original Este \u00edtem est\u00e1 sujeto a una licencia Creative Commons "}